Get the app
US › Healthcare

eXoZymes, Inc. (EXOZ)

US · Healthcare · Biotechnology

$4.09+2.25%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-2.9M
EPS
$-0.33

Key statistics

Market cap
$42.7M
Forward P/E
0.0
P/B
16.21
Book value
$0.39
EPS (TTM)
$-1.19
52-week high
$18.40
52-week low
$4.35
50-day MA
$6.12
200-day MA
$8.23

Shareholding

Insiders
65.35%
Institutions
1.34%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC0.59%
Davidson Kahn Capital Management, LLC0.27%
Geode Capital Management, LLC0.25%
BlackRock Inc0.10%
Vanguard Fiduciary Trust Co0.10%
Morgan Stanley - Brokerage Accounts0.01%
Tower Research Capital LLC0.00%
Mercer Global Advisors Inc.0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for eXoZymes, Inc. — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.